The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans Aged 55+. It Combines Pharmacist Counseling and CHW Support to Improve Blood Pressure Control in Hypertension Management.
Check, Monitor, Control Hypertension in Older African American Adults (#Check, Monitor, Control)
2 other identifiers
interventional
480
1 country
1
Brief Summary
The proposed study, "Check, Monitor, Control Hypertension in Older African American Adults," is a randomized clinical trial designed to improve blood pressure control among African American adults aged 55 years and older in the Greater Houston area. Hypertension disproportionately affects African Americans, contributing to higher rates of cardiovascular disease and stroke. This project aims to improve clinical and behavioral outcomes through a 24-month intervention combining pharmacist-led counseling and Community Health Worker (CHW) support.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Jun 2026
Longer than P75 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2026
CompletedFirst Posted
Study publicly available on registry
February 17, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2028
Study Completion
Last participant's last visit for all outcomes
May 31, 2030
April 13, 2026
April 1, 2026
2 years
February 9, 2026
April 8, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Systolic Blood Pressure
Mean change in systolic blood pressure (mmHg) from baseline to 24 months, measured using standardized BP readings.
Baseline, 6 months, 12 months, 18 months, 24 months
Secondary Outcomes (3)
Change in Diastolic Blood Pressure
Baseline, 6 months, 12 months, 18 months, 24 months
Medication Adherence
Baseline, 6 months, 12 months, 18 months, 24 months
Lifestyle Behavior Changes
Baseline, 6 months, 12 months
Study Arms (2)
Pharmacist Only (Control Group)
ACTIVE COMPARATORParticipants receive usual hypertension care as per standard practice provided by a clinical pharmacists
Combined Intervention (Pharmacists + CHW Interventions)
EXPERIMENTALParticipants receive both Pharmacist and CHW Counseling and Support
Interventions
Medication management and disease state counseling provided by a clinical pharmacist.
Participants receive CHW Individual patient assistance and group health workshops in addition to pharmacist interventions
Eligibility Criteria
You may qualify if:
- Individuals are eligible to the study if they are:
- years or older
- Have at least 2 high blood pressure readings ≥ 130/80 mmHg within one month
- Past Medical History of hypertension \> 1 year
- Taking at least 1 antihypertensive medication
- Independent Activities of Daily Livings (ADL) and instrumental Activities of Daily Livings (iADL)
- Have a SmartPhone
- Live within the Greater Houston Metropolitan Areas
- Able to speak English
You may not qualify if:
- Unable to verbalize comprehension of study or impaired cognitive function (e.g. dementia)
- Not able to monitor blood pressure at home
- Plans to relocate outside Houston within the next year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
3100 Cleburne Street, Nabrit Science Building,
Houston, Texas, 77004, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ivy O Poon, Pharm.D., M.S., BCPS
Texas Southern University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2026
First Posted
February 17, 2026
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
May 31, 2028
Study Completion (Estimated)
May 31, 2030
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will be available beginning 12 months after publication of primary results and will remain accessible for at least 5 years.
- Access Criteria
- Researchers must submit a data use request and agree to a data use agreement. Data will be shared through an NIH-approved repository (e.g., dbGaP or similar secure platform).
De-identified individual participant data (IPD) will be shared, including: Baseline demographic and clinical characteristics Intervention adherence data Primary and secondary outcome measures (e.g., blood pressure readings, medication adherence, lifestyle behavior changes)